$AEYE
AUDIOEYE INC Stock $aeye

$aeye Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000114420416118931 Filed on August 15, 2016

Income Statement

Concept	2016 Q2	2015 Q4	2015 Q2
Revenue	$186.9K	$20.00K	$104.4K
YoY Change	78.94%	-91.67%	-96.53%
Cost Of Revenue	$297.8K	$50.00K	$394.5K
YoY Change	-24.52%	-91.07%	18.0%
Gross Profit	-$110.9K	-$20.00K	-$290.1K
YoY Change	-61.77%	-93.75%	-110.83%
Gross Profit Margin	-59.35%	-100.0%	-277.79%
Selling, General & Admin	$1.020M	$610.0K	$2.380M
YoY Change	-57.14%	-76.26%	70.53%
% of Gross Profit
Research & Development	$90.00K	$80.00K	$58.74K
YoY Change	53.22%	-63.64%	-45.69%
% of Gross Profit
Depreciation & Amortization	$0.00	$130.0K	$140.0K
YoY Change	-100.0%	85.71%	16.67%
% of Gross Profit
Operating Expenses	$1.241M	$830.0K	$2.570M
YoY Change	-51.72%	-70.88%	53.28%
Operating Profit	-$1.352M	-$850.0K	-$2.860M
YoY Change	-52.73%	-73.19%	-385.42%
Interest Expense	-$566.3K	$100.0K	$157.00
YoY Change	-360789.17%		-65.94%
% of Operating Profit
Other Income/Expense, Net	-$2.160M	$0.00	$157.00
YoY Change	-1375771.97%		-134.06%
Pretax Income	-$3.510M	-$750.0K	-$2.860M
YoY Change	22.73%	-76.71%	50.53%
Income Tax
% Of Pretax Income
Net Earnings	-$3.512M	-$750.0K	-$2.860M
YoY Change	22.79%	-76.71%	-385.53%
Net Earnings / Revenue	-1879.3%	-3750.0%	-2738.82%
Basic Earnings Per Share
Diluted Earnings Per Share	-$893.1K	-$229.4K	-$899.4K
COMMON SHARES
Basic Shares Outstanding		81.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2015 Q4	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.200M	$1.740M	$1.210M
YoY Change	81.82%	0.0%	112.28%
Cash & Equivalents	$2.144M	$1.687M	$1.145M
Short-Term Investments	$50.00K	$50.00K	$60.00K
Other Short-Term Assets	$40.00K	$40.00K	$120.0K
YoY Change	-66.67%	-55.56%	71.43%
Inventory
Prepaid Expenses
Receivables	$26.29K	$22.74K	$20.00K
Other Receivables	$0.00	$0.00	$10.00K
Total Short-Term Assets	$2.265M	$1.805M	$1.350M
YoY Change	67.75%	-44.87%	-68.54%
LONG-TERM ASSETS
Property, Plant & Equipment		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Goodwill		$700.5K
YoY Change		0.0%
Intangibles	$2.603M	$2.841M
YoY Change		-8.28%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$3.305M	$3.541M	$3.560M
YoY Change	-7.15%	-6.77%	-22.63%
TOTAL ASSETS
Total Short-Term Assets	$2.265M	$1.805M	$1.350M
Total Long-Term Assets	$3.305M	$3.541M	$3.560M
Total Assets	$5.570M	$5.346M	$4.910M
YoY Change	13.44%	-24.41%	-44.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$190.0K	$210.0K	$550.0K
YoY Change	-65.45%	-73.08%	-52.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$20.00K	$20.00K	$20.00K
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$4.690M	$891.2K	$610.0K
YoY Change	668.85%	-22.95%	-53.51%
LONG-TERM LIABILITIES
Long-Term Debt	$10.00K	$1.920M	$40.00K
YoY Change	-75.0%	3740.0%	-42.86%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$10.00K	$1.923M	$40.00K
YoY Change	-75.0%	3613.32%	-39.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.690M	$891.2K	$610.0K
Total Long-Term Liabilities	$10.00K	$1.923M	$40.00K
Total Liabilities	$4.700M	$2.815M	$640.0K
YoY Change	634.38%	132.9%	-53.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.26M	-$24.24M
YoY Change		42.33%
Common Stock		$817.00
YoY Change		5.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$623.0K	$623.0K
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity	$870.2K	$2.532M	$4.270M
YoY Change
Total Liabilities & Shareholders Equity	$5.569M	$5.346M	$4.910M
YoY Change	13.41%	-24.41%	-44.79%

Cashflow Statement

Concept	2016 Q2	2015 Q4	2015 Q2
OPERATING ACTIVITIES
Net Income	-$3.512M	-$750.0K	-$2.860M
YoY Change	22.79%	-76.71%	-385.53%
Depreciation, Depletion And Amortization	$0.00	$130.0K	$140.0K
YoY Change	-100.0%	85.71%	16.67%
Cash From Operating Activities	-$510.0K	-$670.0K	-$1.360M
YoY Change	-62.5%	-67.16%	257.89%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$190.0K	$0.00
YoY Change		-258.33%	-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	$0.00	-$190.0K	$0.00
YoY Change		-371.43%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.580M	2.500M	1.740M
YoY Change	-9.2%	67.79%	145.07%
NET CHANGE
Cash From Operating Activities	-510.0K	-670.0K	-1.360M
Cash From Investing Activities	0.000	-190.0K	0.000
Cash From Financing Activities	1.580M	2.500M	1.740M
Net Change In Cash	1.070M	1.640M	380.0K
YoY Change	181.58%	-441.67%	1800.0%
FREE CASH FLOW
Cash From Operating Activities	-$510.0K	-$670.0K	-$1.360M
Capital Expenditures	$0.00	-$190.0K	$0.00
Free Cash Flow	-$510.0K	-$480.0K	-$1.360M
YoY Change	-62.5%	-77.78%	1842.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	1923499	USD
CY2016Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	416449	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	60790	USD
CY2016Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3999298	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	90006306	shares
CY2016Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	139835	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2159805	USD
CY2015Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	594641	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	278373	USD
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	267888	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	2264596	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41388	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	1804986	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41388	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2603455	USD
CY2016Q2	us-gaap	Long Term Debt LongTermDebt	11800	USD
CY2015Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	439361	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5568579	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22741	USD
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	623000	USD
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	623000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33754111	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27393238	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32261947	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24239431	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	870238	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	2531626	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5346370	USD
CY2016Q2	us-gaap	Cash Cash	2144220	USD
CY2015Q4	us-gaap	Cash Cash	1687257	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26288	USD
CY2016Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2700	USD
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3600	USD
CY2016Q2	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	50000	USD
CY2015Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	50000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	592572	USD
	us-gaap	Cost Of Revenue CostOfRevenue	856633	USD
	us-gaap	Gross Profit GrossProfit	-281011	USD
	us-gaap	Gross Profit GrossProfit	-651172	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	317567	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	576396	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	170613	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	201020	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1292923	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4188547	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	278373	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	267888	USD
	us-gaap	Operating Expenses OperatingExpenses	2059476	USD
	us-gaap	Operating Expenses OperatingExpenses	5233851	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2340487	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5885023	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	311561	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	205461	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-3341151	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-676447	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3264	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5682029	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3264	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8022516	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5881759	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	297764	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	79139308	shares
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	40000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	594641	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8062516	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	394502	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	-110905	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	-290079	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	194201	USD
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	210029	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58738	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	1240930	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	2570031	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1351835	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2860110	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	186859	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	104423	USD
CY2016Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	70908	USD
CY2015Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2016Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-566282	USD
CY2015Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	157	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	157	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-3511640	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2859953	USD
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	98295458	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	79531225	shares
CY2016Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	18125	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3529765	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3454594	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6476400	USD
CY2016Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1714153	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1435780	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2840856	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2603455	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	278373	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	267804	USD
CY2015Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2500000	USD
CY2016Q2	aeye	Working Capital Amount WorkingCapitalAmount	2421945	USD
CY2016Q2	aeye	Working Capital WorkingCapital	1577353	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	1500	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	688292	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1500270	USD
	aeye	Common Stock Issuance Costs CommonStockIssuanceCosts	664497	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	600301	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3547	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-246094	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	93439	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-227928	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1069147	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3775711	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-40972	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-29650	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1579082	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	325000	USD
	aeye	Increase Decrease In Stock Subscription Receivable IncreaseDecreaseInStockSubscriptionReceivable	0	USD
	aeye	Increase Decrease In Stock Subscription Receivable IncreaseDecreaseInStockSubscriptionReceivable	-1175000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1567082	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3277942	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	456963	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-527419	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1687257	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1672901	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2144220	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1145482	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	43942	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	24382	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	40972	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	29650	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	307	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-12000	USD
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-16000	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-93938	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-228983	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	355659	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	aeye	Common Stock Issuance Costs CommonStockIssuanceCosts	28458	USD
CY2015Q4	aeye	Class Of Warrant Or Right Exercisable Number ClassOfWarrantOrRightExercisableNumber	25000000	shares
CY2016Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2015Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1899699	USD
CY2015Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2500000	USD
CY2015	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2500000	USD
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	4603155	USD
CY2015Q4	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	41047920	shares
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	627293	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	20846639	shares
	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.02
	aeye	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P4Y8M8D
CY2015	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	42526609	shares
CY2016Q2	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber	63070958	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	63274082	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.22
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.15
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y1M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y11M26D
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	1167	USD
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	160000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	160000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107250100	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81717154	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107250100	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81717154	shares
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	AUDIOEYE INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001362190
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	AEYE
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107333432	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	3341151	USD
CY2015Q4	aeye	Common Stock Issuance Price Per Share CommonStockIssuancePricePerShare	0.10
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Reclassification</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain prior year amounts have been reclassified to conform to the current year presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2	aeye	Common Stock Issuance Price Per Share CommonStockIssuancePricePerShare	0.25
CY2016Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3205959	USD
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1312000	USD
CY2016Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1579082	USD
	us-gaap	Fair Value Assumptions Weighted Average Volatility Rate FairValueAssumptionsWeightedAverageVolatilityRate	1.7295	pure
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	Vesting shall only occur if the closing share price of the Companys common stock on each of the 20 trading days before and including the end of any performance period is not less than $0.20 per share (market condition).
CY2016Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	83336	shares
CY2016Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	14292	USD
CY2016Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	12834800	shares
CY2016Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1025000	USD
CY2016Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	11714285	shares
CY2016Q2	aeye	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1312000	shares
CY2016Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1579082	USD
CY2016Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	554160	USD
CY2016Q2	aeye	Stock Issued During Period Shares Conversion Of Preferred Stock StockIssuedDuringPeriodSharesConversionOfPreferredStock	900525	shares
CY2016Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	15000	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	14292	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1078123	USD
	aeye	Common Stock And Warrants Issued During Period Value New Issues CommonStockAndWarrantsIssuedDuringPeriodValueNewIssues	1579082	USD
	aeye	Stock Issued During Period Value Conversion Of Preferred Stock StockIssuedDuringPeriodValueConversionOfPreferredStock	0	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3205959	USD
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-218786	USD
	aeye	Adjustments To Additional Paid In Capital Warrant And Options Issued For Services AdjustmentsToAdditionalPaidInCapitalWarrantAndOptionsIssuedForServices	688292	USD
CY2016Q2	aeye	Class Of Warrant Or Right Expiration Term ClassOfWarrantOrRightExpirationTerm	P5Y
	us-gaap	Debt Conversion Description DebtConversionDescription	In connection with the transaction, the Company also entered into amendments to certain agreements. On April 18, 2016, the Company entered into a First Amendment to Note and Warrant Purchase Agreement (the “Purchase Agreement Amendment”) and an Omnibus Amendment to Secured Promissory Notes (the “Note Amendment”), which collectively amend that certain Note and Warrant Purchase Agreement dated as of October 9, 2015 (the “Original Agreement”) and the convertible promissory notes previously issued thereunder to, among other things (i) remove the right of Anthion Partners II, LLC (together with its affiliates, “Anthion”) to designate a member of the Board of Directors of the Company; (ii) amend the convertible promissory notes issued thereunder to provide that if a change of control of the Company occurs prior to the maturity date or an equity financing (as defined therein), the convertible promissory note shall be repaid in an amount equal to the product of (a) 1.4 and (b) the outstanding principal amount and all accrued and unpaid interest thereunder; (iii) reduce the conversion threshold in the definition of “qualified financing” under the convertible promissory notes from $2,000,000 to $1,000,000; (iv) remove the security interest feature from the form of convertible promissory note that may be issued in the future under the Original Agreement, as amended, and (v) provide for optional conversion into warrants containing “blocker” provisions (“Special Warrants”) instead of shares upon an equity financing. The Company also made certain amendments to outstanding warrants to add similar “blocker” provisions.
	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	0	USD
	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	-91408	USD
CY2016Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18353310	shares
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1078123	USD
	aeye	Warrant Issued In Settlement Of Conventiable Note Payable And Accured Interest WarrantIssuedInSettlementOfConventiableNotePayableAndAccuredInterest	1541678	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1750000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	aeye	Warrant Issued In Settlement Of Conventiable Note Payable And Accured Interest WarrantIssuedInSettlementOfConventiableNotePayableAndAccuredInterest	0	USD
CY2016Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18353310	shares
CY2016Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2016Q2	us-gaap	Share Price SharePrice	0.161
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0101	pure
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3999298	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14166	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	9	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2015Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	14166	USD
CY2015Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	83332	shares
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	58794	USD
	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	3000	USD
	aeye	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expired In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod	99166	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.50
CY2016Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	218786	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-900	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-900	USD
CY2015Q2	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	USD
CY2016Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1664281	USD
CY2015Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1664281	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	750	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	750	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	218786	USD
	aeye	Deemed Dividend Beneficial Conversion Feature On Convertible Preferred Stock DeemedDividendBeneficialConversionFeatureOnConvertiblePreferredStock	0	USD
	aeye	Deemed Dividend Beneficial Conversion Feature On Convertible Preferred Stock DeemedDividendBeneficialConversionFeatureOnConvertiblePreferredStock	594641	USD

Files In Submission

Name	View Source	Status
0001144204-16-118931-index-headers.html	Edgar Link	pending
0001144204-16-118931-index.html	Edgar Link	pending
0001144204-16-118931.txt	Edgar Link	pending
0001144204-16-118931-xbrl.zip	Edgar Link	pending
aeye-20160630.xml	Edgar Link	completed
aeye-20160630.xsd	Edgar Link	pending
aeye-20160630_cal.xml	Edgar Link	unprocessable
aeye-20160630_def.xml	Edgar Link	unprocessable
aeye-20160630_lab.xml	Edgar Link	unprocessable
aeye-20160630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v445519_10q.htm	Edgar Link	pending
v445519_ex31-1.htm	Edgar Link	pending
v445519_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AEYE
AUDIOEYE INC Stock $aeye

2016 Q2 Form 10-Q Financial Statement

#000114420416118931 Filed on August 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AEYE AUDIOEYE INC Stock $aeye

2016 Q2 Form 10-Q Financial Statement

#000114420416118931 Filed on August 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AEYE
AUDIOEYE INC Stock $aeye